Humoral response among patients with interstitial lung disease vaccinated with the BNT162b2 SARS-Cov-2 vaccine: a prospective cohort study

Overview of attention for article published in Respiratory Research, September 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Readers on

mendeley: 16 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 2 X users, with an upper bound of 3,036 followers.

IPF patients treated with antifibrotic therapy mount an adequate immune response to the mRNA COVID-19 vaccine. Our latest publication in Respiratory Research

09 Sep 2022

Reply Repost Favourite

New article: Humoral response among patients with interstitial lung disease vaccinated with the BNT162b2 SARS-Cov-2 vaccine: a prospective cohort study https://t.co/xV5XSehczn

02 Sep 2022

Reply Repost Favourite

RT @barakpertzov: Does antifibrotic treatment diminish the immune response to the mRNA COVID vaccines in IPF patients? Our latest publicat…

01 Sep 2022

Reply Repost Favourite

Does antifibrotic treatment diminish the immune response to the mRNA COVID vaccines in IPF patients? Our latest publication in respiratory research https://t.co/GyheWxfxW8 #IPF @BioMedCentral

01 Sep 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.